Technology · Synbio & enabling tech / Genome engineering
Xenobiology & expanded genetic alphabet (XNA)
Orthogonal biological systems built on xeno-nucleic acids, unnatural base pairs and genomically recoded organisms that incorporate noncanonical amino acids into proteins — enabling site-specific drug conjugation and a genetic firewall against horizontal gene transfer with wild species.
1 · What it gives
Xenobiology designs orthogonal biological systems chemically isolated from the natural biosphere — organisms built on xeno-nucleic acids (XNA), unnatural base pairs, or genomically recoded codons that incorporate noncanonical amino acids (ncAAs) into proteins. Sanofi’s Synthorx platform, acquired for $2.5 billion, produces SAR-444245 (pegenzileukin, also called THOR-707), an engineered “not-alpha” IL-2 cytokine that uses site-specific PEGylation through an ncAA to eliminate the vascular-leak toxicity of classical IL-2; the PEGATHOR study (NCT05104567) reported results in June 2026 testing it in combination with pembrolizumab and other checkpoint inhibitors. Firebird Biomolecular Sciences, built on Steven Benner’s Hachimoji (eight-letter) DNA system, contributed to a June 2026 Nature Communications study expanding triplex-forming oligonucleotide recognition of DNA using the expanded genetic alphabet (AEGIS), identifying modular base triads for programmable, sequence-specific applications. Scripps Research reported a March 2026 Nature Chemistry study on multi-type rare codon recoding that enables site-specific incorporation of up to five distinct ncAAs simultaneously in mammalian cells, alongside a separate reprogrammed genetic code expanding to 32 total amino acids. Yale University’s Farren Isaacs lab unveiled “Ochre” in February 2025, a next-generation genomically recoded organism (GRO) that fully compresses redundant codons into a single stop codon, succeeding the earlier C321.ΔA strain and enabling programmable-protein production for therapeutic and industrial applications. KU Leuven’s Rega Institute (Piet Herdewijn’s group) published structural work on a Thermococcus kodakarensis DNA polymerase engineered for HNA (hexose nucleic acid) reverse transcription, providing the first structural insight into how a DNA polymerase processes a xeno-nucleic acid. In China, Peking University researchers Chen Peng and Yi Chengqi published a June 2025 codon-expansion strategy using post-transcriptionally modified RNA codons to incorporate ncAAs into mammalian cells without disturbing the natural genetic code.
The key directions of xenobiology and the expanded genetic alphabet are:
- Xeno-nucleic acids (XNA): DNA-like polymers with the deoxyribose sugar replaced by alternative sugars (hexose/HNA, threose/TNA, glycerol/GNA, arabinose/ANA), giving near-total resistance to natural nucleases.
- Unnatural base pairs (UBPs): artificial nucleotides that pair via mechanisms other than Watson-Crick hydrogen bonding, enabling semi-synthetic organisms that stably propagate a six- or eight-letter genetic code across hundreds of generations.
- Genetic code expansion via amber suppression: reprogramming the amber (UAG) stop codon with an orthogonal tRNA/synthetase pair to insert a noncanonical amino acid at a precise protein position instead of terminating translation.
- Genomically recoded organisms (GROs): removing a specific codon entirely from a genome (and its corresponding release factor), freeing that codon as a dedicated, collision-free channel for ncAA incorporation.
Sectoral value chain#
[Orthogonal pair design] ──> [Chemical synthesis of XNA/ncAA] ──> [Genomically recoded organism (GRO) assembly]
│
(Amber-suppression translation)
│
[Therapeutic XNA aptamers] <─── [Click-chemistry ADC conjugation] <─── [ncAA-protein isolation]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Orthogonal design | Computational modeling of non-biological nucleotide pairs and the 3D structure of orthogonal tRNA/synthetase pairs. | In: Protein crystallography data, quantum-chemistry and docking software. Out: Molecular specifications for UBP structures and enzyme active sites. |
| XNA/ncAA synthesis | De novo chemical synthesis of high-purity unnatural nucleoside triphosphates (dNTPs) and noncanonical amino acids. | In: Chemical precursors, organic-synthesis reagents. Out: Crystalline ncAAs and solutions of orthogonal dNTPs. |
| Genome recoding (GRO assembly) | De novo construction of chromosomes with target codons replaced and the corresponding release-factor gene knocked out. | In: Multiplex CRISPR cassettes, MAGE/CAGE systems, wild-type bacteria. Out: Stable genomically recoded host strain (GRO). |
| Suppression translation (fermentation) | Culturing the GRO strain in the presence of an ncAA to express proteins with site-specific incorporation of the artificial amino acid. | In: GRO bacteria, fermenters, mineral media, ncAA supplements. Out: Crude recombinant protein bearing an orthogonal reactive tag. |
| Click conjugation | Chemically joining the purified protein to a payload molecule (PEG, toxin) via copper-free click chemistry (SPAAC). | In: ncAA-protein, click linkers bearing toxin/PEG, catalysts. Out: Homogeneous, high-purity antibody-drug conjugate with a fixed drug-to-protein ratio. |
| XNA application | Directed evolution (SELEX) of xeno-nucleic acids to generate stable therapeutic aptamers and molecular sensors. | In: XNA libraries, evolved polymerases, target molecules. Out: Stable, injectable XNA-based therapeutics. |
Cross-cutting technologies of the sector:
- Compartmentalized self-replication (CSR): directed in vitro evolution of polymerases inside water-in-oil emulsion droplets, each containing a single cell with a mutant polymerase gene and XNA substrates, selecting for enzymes able to synthesize genes using an artificial nucleic-acid backbone.
- Copper-free click chemistry (SPAAC): a highly selective reaction between azide and cyclooctyne (DBCO) groups integrated into noncanonical amino acids, proceeding under physiological conditions without toxic copper catalysts, essential for injectable-drug manufacturing.
- Multiplex Automated Genome Engineering (MAGE): cyclic introduction of dozens of single-stranded DNA oligonucleotides into dividing bacterial cells via lambda-Red recombination proteins, enabling rapid replacement of hundreds of codons genome-wide within days.
2 · What it replaces 0 · matched by industry
No graded substitution linked yet.
3 · How to implement 6 steps
- 1Computational design of the ncAA insertion siteData, software & automationProtein-engineering software identifies a surface-exposed, non-catalytic position on the target protein (e.g., IL-2) suitable for site-specific ncAA incorporation without disrupting receptor-binding activity.Who can do this step matched automaticallyUMAMI Bioworks Singapore“Umami Bioworks (Singapore; address 89 Science Park Dr, 04-22) is a B2B cultivated seafood platform/licensing company that enables seafood producers to grow “not caught” species …”163,050 tonnes“As the fundamental component of 5G deployment, optic fibre is critical to making Hong Kong a smart city and laying the groundwork for IoT.”N.Thing South Koreaindustrial scale“Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by …”
- 2Synthesis of orthogonal reagentsSynthesis & conversionPara-azidophenylalanine (pAzF) or a similar clickable noncanonical amino acid is synthesized alongside its cognate orthogonal aminoacyl-tRNA synthetase, engineered to charge only the intended tRNA with this specific ncAA.Who can do this step matched automatically163,050 tonnes“Uniquely equipped with the credentials for the R&D, design, and production of both high-efficiency dust filtration materials and SCR denitration catalysts, as well as for the …”pilot scale“Key partners/customers include JAL, Airbus, Nippon Paper Industries, Sumitomo Corporation (pure Japan-domestic wood-based SAF MoU); Idemitsu Kosan & Morisora Biorefinery (ATJ-SAF …”BBCA Group 丰原集团 Chinaindustrial scale“First-generation biomanufacturing: Fermentation-based production of organic acids, amino acids, vitamins, alcohols, and related bio-based products from starch (corn, cassava) using …”
- 3GRO fermentation with amber suppressionFermentation & cultivationA genomically recoded E. coli strain is fermented in the presence of the ncAA; the orthogonal tRNA/synthetase pair inserts the ncAA at the reprogrammed codon position, producing a crude protein bearing a single, precisely positioned clickable handle.Who can do this step matched automatically✓ ISO 9001 75,000 tons industrial scale“Henan Jindan Lactic Acid Technology Co., Ltd.（金丹科技，SZ300829）研发、生产和销售L-乳酸及乳酸盐（乳酸钠、乳酸钙）等发酵产品，产品用于食品、饲料、生物降解材料（PLA等原料）、工业与医药等领域；公司采用现代微生物发酵技术，拥有自研菌种育种体系及乳酸制备、提纯等核心工艺，并具备国家级研发平台与多项专利。公 …”Ajinomoto Japanindustrial scale“It specializes in amino acid fermentation technology, applying it to seasonings, processed foods, frozen foods, and healthcare solutions.”✓ ISO 9001 115,000 tons industrial scale“四大核心技术方向：微生物代谢途径与高效工程菌构建、代谢调控与高效转化、发酵体系分离纯化、聚合工艺及下游应用开发”✓ ISO 9001 industrial scale“在全球范围内以规模化发酵工艺和多菌种自有工程平台为支撑，具备显著的成本领先和应用落地能力。”Tsingke Biotechnology China“Their platform supports large libraries (up to ~1,500 candidates/day) with diverse expression systems and rapid gene-to-antibody delivery, backed by ISO-certified facilities and …”
- 4Isolation of purified azido-proteinPurification & downstreamThe azide-tagged protein is purified from the fermentation broth using standard chromatography, yielding a homogeneous preparation with the reactive group exposed at one defined site.Who can do this step matched automaticallyHLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”Alfa Laval Sweden✓ ISO 9001“Here we compare the three most common options: centrifugation, filtration and coalescence.”Space F South Korea“2026-07-12 [Korea's next drug lab is in orbit - The Korea Herald — Space LiinTech is advancing Korea’s foray into space-based drug research with autonomous microgravity platforms …”Algal Bio Japanindustrial scale“・Equipped with comprehensive downstream processing capabilities (Concentration, sterilization, and drying)”
- 5SPAAC click conjugation with PEG-DBCO linkerThe purified protein is reacted with a DBCO-functionalized PEG or drug-linker molecule via strain-promoted azide-alkyne cycloaddition, forming a stable triazole linkage without any toxic copper catalyst, at a fixed one-to-one conjugation ratio.
- 6GMP purification, QC and fill-finishPurification & downstreamPackaging & fill-finishThe conjugate undergoes final GMP-grade purification and quality-control testing to confirm conjugation homogeneity and purity, before aseptic fill-finish into vials for clinical or commercial distribution.Who can do this step matched automaticallyHLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”Alfa Laval Sweden✓ ISO 9001“Here we compare the three most common options: centrifugation, filtration and coalescence.”Space F South Korea“2026-07-12 [Korea's next drug lab is in orbit - The Korea Herald — Space LiinTech is advancing Korea’s foray into space-based drug research with autonomous microgravity platforms …”Algal Bio Japanindustrial scale“・Equipped with comprehensive downstream processing capabilities (Concentration, sterilization, and drying)”Alterpacks Singapore“[Alterpacks - New Materials Solutions — AlterPacks is a Singapore-based startup that develops sustainable packaging materials sourced from agricultural by-products.”
4 · Who delivers
Matched suppliers (matched automatically)
| Daesang | South Korea | Producer | active |
| Blue Ocean Barns | United States | Not classified | active |
In the services and supply catalogue 1 · paid service
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Sanofi (Synthorx) | 🇫🇷 France | SAR-444245 (pegenzileukin/THOR-707) | Semi-synthetic organism with ncAA-based site-specific PEGylation | operating |
| Firebird Biomolecular Sciences | 🇺🇸 USA | Hachimoji DNA, AEGIS expanded alphabet | Eight-letter genetic alphabet for ultra-sensitive diagnostics | operating |
| Scripps Research Institute | 🇺🇸 USA | Multi-type rare codon recoding | Simultaneous incorporation of up to 5 distinct ncAAs | research |
| Yale University (Isaacs Lab) | 🇺🇸 USA | “Ochre” genomically recoded organism | Next-gen GRO succeeding C321.ΔA, single dedicated stop codon | research |
| KU Leuven (Rega Institute) | 🇧🇪 Belgium | HNA/XNA polymerase engineering | First structural map of DNA polymerase processing HNA | research |
| Peking University | 🇨🇳 China | Mammalian codon-expansion strategy | Post-transcriptionally modified RNA codons for ncAA incorporation | research |
5 · Rules & route to market
United States
The United States leads global commercialization of xenobiology-derived drugs and genomically recoded strains, anchored by Scripps, Yale and major pharmaceutical acquisitions.
Sanofi’s commercial Synthorx platform, Firebird’s expanded-alphabet diagnostics, Scripps’ multi-ncAA recoding, Yale’s next-gen “Ochre” GRO#
- Sanofi (Synthorx): its SAR-444245 (pegenzileukin/THOR-707), an engineered IL-2 cytokine using site-specific PEGylation through an ncAA, reported PEGATHOR (NCT05104567) combination results with pembrolizumab in June 2026, eliminating the vascular-leak toxicity that limited classical IL-2 therapy.
- Firebird Biomolecular Sciences: built on Steven Benner’s Hachimoji eight-letter DNA/RNA system, contributed to a June 2026 Nature Communications study expanding triplex-forming oligonucleotide DNA recognition using the expanded genetic alphabet (AEGIS) for programmable, sequence-specific applications.
- Scripps Research and Yale University: Scripps reported a March 2026 multi-type rare codon recoding system enabling simultaneous site-specific incorporation of up to five distinct ncAAs in mammalian cells; Yale’s Farren Isaacs lab unveiled “Ochre” in February 2025, a next-generation genomically recoded organism succeeding the earlier C321.ΔA strain.
European Union
The European Union leads xeno-nucleic-acid chemistry and alternative sugar-phosphate backbone engineering, anchored by KU Leuven’s structural biology of XNA polymerases.
KU Leuven’s HNA polymerase structural biology, Rega Institute’s XNA synthesis leadership#
- KU Leuven (Rega Institute): Piet Herdewijn’s group published structural work on a Thermococcus kodakarensis DNA polymerase (KOD-H4) engineered for HNA (hexose nucleic acid) reverse transcription, providing the first structural insight into how a DNA polymerase processes a xeno-nucleic acid backbone.
- XNA chemistry leadership: KU Leuven remains a leading academic center for the chemical synthesis of hexose nucleic acids and related xeno-nucleic-acid backbones, building the structural foundation for stable, nuclease-resistant XNA aptamers and diagnostic sensors.
China
China is building genetic-code-expansion capability through university chemistry and life-sciences labs, targeting mammalian-cell applications for biomedical research and diagnostics.
Peking University’s mammalian codon-expansion strategy, national grant-funded synthetic genetics programs#
- Peking University: researchers Chen Peng (College of Chemistry and Molecular Engineering) and Yi Chengqi (School of Life Sciences) published a June 2025 codon-expansion strategy using post-transcriptionally modified RNA codons — distinct from all 64 standard codons — to incorporate ncAAs into mammalian systems without disturbing the natural genetic code.
- National grant funding: China’s genetic-code-expansion and synthetic-genetics research is substantially funded through National Natural Science Foundation of China (NSFC) grants supporting university chemistry and life-sciences departments.
- Application focus: Chinese groups working in this Industry emphasize mammalian-cell-compatible codon expansion for biomedical protein engineering rather than the bacterial genomically recoded organisms that dominate the US commercial pipeline.
6 · Money: tenders & grants
7 · Tech stack & innovations
The xenobiology stack layers three distinct orthogonal-biology approaches, each solving a different piece of the genetic-code-expansion problem:
- Semi-synthetic organisms (SSOs):
- Bacteria carrying artificial base pairs (such as d5SICS-dNaM) held together by hydrophobic interactions rather than hydrogen bonds; because the cell cannot synthesize the unnatural nucleoside triphosphates itself, a nucleotide-transporter gene from diatoms (PtNTT2) is engineered into its membrane so it imports the artificial nucleotides supplied in growth media, enabling stable propagation of a six- or eight-letter genetic code.
- Amber codon suppression:
- An orthogonal aminoacyl-tRNA synthetase/tRNA pair, typically sourced from a different domain of life (e.g., archaeal Methanosarcina barkeri) to avoid cross-reactivity with the host’s native tRNAs, recognizes the reprogrammed UAG stop codon and inserts a noncanonical amino acid into the growing peptide chain instead of terminating translation.
- Genomically recoded organisms (GROs):
- Every instance of a target codon (e.g., UAG) is replaced genome-wide with a synonymous codon, then the gene encoding the corresponding release factor is deleted, freeing that codon as a collision-free channel that can encode any of 100+ noncanonical amino acids at near-100% efficiency.
Sources 6 · 0 independent · 6 producer sites
Producers' own sites 6
- Sanofi producer checked 2026-06-30 · link not kept
- Firebird biomolecular producer checked 2026-07-03 · link not kept
- Ku leuven producer checked 2026-03-01 · link not kept
- Scripps research producer checked 2026-06-22 · link not kept
- Yale isaacs lab producer checked 2026-06-22 · link not kept
- Peking university producer checked 2026-07-05 · link not kept